Baidu
map

Conversion therapy with an immune checkpoint inhibitor and an antiangiogenic drug for advanced hepatocellular carcinoma: A review

Tang, HW; Cao, YB; Jian, YP; Li, XR; Li, JF; Zhang, WW; Wan, T; Liu, Z; Tang, W; Lu, SC

Lu, SC (通讯作者),Chinese Peoples Liberat Army Gen Hosp, Fac Hepatopancreatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.;Lu, SC (通讯作者),Chinese PLA, Inst Hepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.;Lu, SC (通讯作者),Chinese PLA, Key Lab Digital IIepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China.;Tang, W (通讯作者),Natl Ctr Global Hlth & Med, Int Hlth Care Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.

BIOSCIENCE TRENDS, 2022; 16 (2): 130

Abstract

Hepatocellular carcinoma (HCC) has been the fifth most common malignancy worldwide and is the second most common cause of tumor-related mortality glob......

Full Text Link


Baidu
map
Baidu
map
Baidu
map